Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
multispectral imaging, and will develop low-cost, portable devices to detect the earliest signs of cancer. The OASIS hub is being funded by a grant of £11million from the UK’s Engineering and Physical Sciences
-
you will be providing key input into intervention development, and ultimately a potential medical device that could become adopted into clinical practice, not just in the UK but globally. You will be
-
maintenance of large-scale GPU clusters within our data centres, ensuring optimal performance and reliability. Strategy Development: Develop, execute and evangelize GPU strategy which considers platform
-
, as opposed to the development of new clients. As needed, you will research new business opportunities, using a variety of channels and methods including social media, networking designated target
-
looking for a visionary leader to join us at the heart of this journey. As Head of Platform you’ll lead the development and delivery of a digital strategy for the Property Division to address a fragmented
-
Protection and Imperial Codes of Practice. You will have experience and expertise in protective security, alongside excellent organisational and interpersonal skills that will be used to develop best practice
-
research in paediatric critical care, focusing on developing a breath test for bacterial lower respiratory tract infections in ventilated children. You will collect and manage breath samples, collaborate
-
including non-NHS and non-healthcare related studies With the support of the Senior RGIT Team, you will lead on development, implementation and enforcement of the audit programme for research studies and
-
to generating major impact across one of the World’s leading universities - be a part of a successful team developing research and technologies through collaborations with business and
-
this role, your goal will be to identify hydrolytic enzymes implicated in colorectal cancer using cutting-edge ‘omics’ technologies, work with collaborators to develop chemical inhibitors, and validate